Chadrick Denlinger to Histone Deacetylase Inhibitors
This is a "connection" page, showing publications Chadrick Denlinger has written about Histone Deacetylase Inhibitors.
Connection Strength
0.187
-
Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death. Surgery. 2004 Aug; 136(2):416-25.
Score: 0.055
-
Modulation of antiapoptotic cell signaling pathways in non-small cell lung cancer: the role of NF-kappaB. Semin Thorac Cardiovasc Surg. 2004; 16(1):28-39.
Score: 0.053
-
Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway. J Biol Chem. 2003 May 23; 278(21):18980-9.
Score: 0.050
-
Novel targeted therapies for non-small cell lung cancer. Thorac Surg Clin. 2006 Nov; 16(4):353-66.
Score: 0.016
-
Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species. J Thorac Cardiovasc Surg. 2004 Nov; 128(5):740-8.
Score: 0.014